Barclays
SURG icon

Barclays’s SurgePays SURG Stock Holding History

Barclays’s Portfolio SURG Stock Details SURG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-147
Closed -$1K – 5368
2022
Q3 		$1K Buy
+147
New +$750 ﹤0.01% 4703

Other funds holding SURG

PCM
Praetorian Capital Management Coral Gables, Florida $137M AUM
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Barclays's SURG Position: Q4 2022 in Review

Barclays sold out of SurgePays (SURG) in Q4 2022, closing a stake of 147 shares — an estimated $1K sold.

Barclays first reported a position in SURG in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 25 funds tracked by Wall St. Rank hold SURG as of Q4 2022.

  • Barclays reported no remaining SurgePays position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 147 SurgePays shares in Q4 2022, an estimated $1K.
  • Barclays first reported a position in SurgePays in Q3 2022 and held it in 1 quarter.
  • Barclays's SurgePays position peaked at $1K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held SurgePays as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.